Rigetti Computing Tripled Its Revenue Last Quarter. Has It Become a Safer Stock to Buy?

Rigetti reported Q1 revenue of $4.4 million, up from $1.5 million a year ago, but operating expenses of roughly $33 million still far exceed sales. The company posted a $33 million profit only because of a $54 million revaluation of derivative warrant liabilities, while 2025 revenue fell about 34%. The article argues quantum computing remains very early-stage and highly risky, with Rigetti’s $5 billion-plus market cap seen as disconnected from fundamentals.

Analysis

The market is still pricing quantum as an option on a technology breakthrough, but the current economics look more like a financing story than a scaling story. The key second-order issue is that lumpy revenue plus high fixed R&D means any near-term “growth” can be overwhelmed by timing noise, so headline prints are poor indicators of durable demand. That creates a wide gap between narrative momentum and the actual runway required to fund development through multiple product cycles.

For incumbents like NVDA and INTC, the relevant effect is not direct displacement but a prolonged spending overhang: customers experimenting with quantum will still spend the bulk of their budget on classical compute, networking, and control systems for years. In that sense, the quantum market acts more like a call option on future architecture shifts than a near-term TAM transfer. The real competitive pressure is likely to hit smaller pure-plays first, because they need capital markets access before they have repeatable end-market pull.

The main risk is valuation compression if the market stops rewarding “early-stage optionality” with public-market multiples. With a multibillion-dollar equity value against a subscale revenue base, any quarter with weak bookings or higher cash burn could reset expectations quickly over days to weeks. Conversely, sustained contract cadence over 2-3 quarters would matter more than one-off top-line spikes, because that is what would validate the existence of a real procurement cycle.

Consensus appears to be overestimating how quickly winners will be identifiable and underestimating how long dilution risk can persist. The better trade is not a blanket short on the theme, but a relative-value expression versus beneficiaries of the same AI compute spend that have real cash flow today. NFLX is only relevant insofar as the article’s own framing highlights how rare true long-duration compounders are; quantum is still years away from that status.

Key Decisions for Investors

• Short RGTIW or buy put spreads into any post-earnings strength: 1-3 month horizon, targeting a reversion if the market starts focusing on cash burn rather than headline revenue growth. Risk/reward favors downside because one weak print can reset multiple expansion quickly.
• Pair trade: long NVDA / short RGTIW for 3-6 months. NVDA captures current AI capex with visible demand and margin support, while RGTIW remains dependent on episodic funding and non-recurring revenue; this isolates the “real compute beneficiary” versus speculative optionality.
• Avoid initiating fresh longs in RGTIW until there are at least 2 consecutive quarters of stable sequential revenue and lower operating loss. The setup is a patience trade, not a momentum trade; entering too early risks multiple compressions on any lumpy quarter.
• For higher-risk accounts, consider a small long-dated call spread on RGTIW only if you want asymmetric exposure to a genuine commercial breakthrough. Structure it with limited premium and a 12-18 month horizon; treat it as venture-style optionality, not a core equity position.
• Use INTC as a neutral hedge rather than a direct beneficiary: if quantum hype cools, capital may rotate back toward companies with existing semiconductor cash flows and manufacturing leverage. The relative move should be modest, but the beta-to-AI infrastructure theme is materially better supported than pure quantum exposure.